Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes. [electronic resource]
Producer: 20120501Description: 128-32 p. digitalISSN:- 1592-8721
No physical items for this record
Publication Type: Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.